These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 33167029)
1. Lymphadenopathy in IgG4-related disease: a phenotype of severe activity and poor prognosis, with eotaxin-3 as a new biomarker. Takanashi S; Kikuchi J; Sasaki T; Akiyama M; Yasuoka H; Yoshimoto K; Seki N; Sugahara K; Chiba K; Kaneko Y; Takeuchi T Rheumatology (Oxford); 2021 Feb; 60(2):967-975. PubMed ID: 33167029 [TBL] [Abstract][Full Text] [Related]
2. Different clinical patterns of IgG4-RD patients with and without eosinophilia. Zhang X; Zhang P; Li J; He Y; Fei Y; Peng L; Shi Q; Zhang W; Zhao Y Sci Rep; 2019 Nov; 9(1):16483. PubMed ID: 31712579 [TBL] [Abstract][Full Text] [Related]
3. Acute lymphoblastic leukemia in a patient with IgG4-related disease. Guo D; Chen D; Chen B Pharmazie; 2018 Jul; 73(7):418-421. PubMed ID: 30001778 [TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G4 (IgG4)-related disease of the stomach - a challenging differential diagnosis in suspected gastric cancer. Probst A; Schaller T; Sommer F; Geissler B; Agaimy A; Messmann H; Märkl B Z Gastroenterol; 2019 Nov; 57(11):1298-1303. PubMed ID: 31739375 [TBL] [Abstract][Full Text] [Related]
5. Severe asthma as the initial clinical manifestation of IgG4-related disease: a retrospective clinical study. Liu X; Shao C; Yu C; Huang H; Pan R; Xu K; Zhang X; Xu Z BMC Pulm Med; 2022 Apr; 22(1):141. PubMed ID: 35413899 [TBL] [Abstract][Full Text] [Related]
6. Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease. Kawashiri SY; Origuchi T; Umeda M; Nishino A; Shimizu T; Fukui S; Koga T; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Maeda T; Kawano M; Yamamoto M; Izumi Y; Kawakami A Arthritis Res Ther; 2018 Dec; 20(1):277. PubMed ID: 30547825 [TBL] [Abstract][Full Text] [Related]
7. IgG4-Related Disease: A Retrospective Chinese Study of Features and Treatment Response of 98 Patients Including 4 Rare Cases. Pan YY; Zhou SC; Wang YJ; Zhu TT; Peng D; Guan HX Curr Med Sci; 2021 Apr; 41(2):390-397. PubMed ID: 33877558 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial. Zhang P; Gong Y; Liu Z; Liu Y; Lin W; Li J; Wang M; Liu X; Fei Y; Chen H; Peng L; Li J; Zhou J; Shi Q; Zhang X; Shen M; Zeng X; Zhang F; Li Y; Zhao Y; Zhang W Int J Rheum Dis; 2019 Aug; 22(8):1479-1488. PubMed ID: 31245907 [TBL] [Abstract][Full Text] [Related]
9. Revealing the distinct clinical patterns and relapse risk factors in seronegative IgG4-RD patients: A retrospective cohort study over a decade. Peng Y; Wang M; Sun R; Nie Y; Zhang N; He X; Sun B; Peng L; Fei Y; Zhou J; Li M; Zhang W J Intern Med; 2024 Aug; 296(2):200-212. PubMed ID: 38924246 [TBL] [Abstract][Full Text] [Related]
10. Thymus and Activation-regulated Chemokine as a Biomarker for IgG4-related Disease. Umeda M; Origuchi T; Kawashiri SY; Koga T; Ichinose K; Furukawa K; Sato T; Tsuji S; Endo Y; Takatani A; Shimizu T; Fukui S; Iwamoto N; Igawa T; Tamai M; Nakamura H; Kawakami A Sci Rep; 2020 Apr; 10(1):6010. PubMed ID: 32265499 [TBL] [Abstract][Full Text] [Related]
11. Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease. Martín-Nares E; Saavedra-González V; Fagundo-Sierra R; Santinelli-Núñez BE; Romero-Maceda T; Calderón-Vasquez K; Hernandez-Molina G Sci Rep; 2021 Jan; 11(1):1832. PubMed ID: 33469111 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary manifestations, treatments and outcomes of IgG4-related disease-a systematic literature review. Dragos C; Joseph C; Elwell H; Dey M; Kouranloo K Rheumatol Int; 2024 Oct; 44(10):1875-1886. PubMed ID: 38769126 [TBL] [Abstract][Full Text] [Related]
13. IgG4-related Lymphadenopathy: A Comparative Study of 41 Cases Reveals Distinctive Histopathologic Features. Bledsoe JR; Ferry JA; Neyaz A; Boiocchi L; Strock C; Dresser K; Zukerberg L; Deshpande V Am J Surg Pathol; 2021 Feb; 45(2):178-192. PubMed ID: 32889888 [TBL] [Abstract][Full Text] [Related]
14. Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse. Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L Arthritis Res Ther; 2018 Oct; 20(1):222. PubMed ID: 30285841 [TBL] [Abstract][Full Text] [Related]
15. Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis. Culver EL; van de Bovenkamp FS; Derksen NIL; Koers J; Cargill T; Barnes E; de Neef LA; Koeleman CAM; Aalberse RC; Wuhrer M; Rispens T J Gastroenterol Hepatol; 2019 Oct; 34(10):1878-1886. PubMed ID: 30345709 [TBL] [Abstract][Full Text] [Related]
16. Biomarkers in IgG4-related disease: A systematic review. Tang J; Cai S; Ye C; Dong L Semin Arthritis Rheum; 2020 Apr; 50(2):354-359. PubMed ID: 31280934 [TBL] [Abstract][Full Text] [Related]
17. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients. Liu Y; Xue M; Wang Z; Zeng Q; Ren L; Zhang Y; Zhang S; Wang Y; Shen D; Xia C; Yu G; Li ZG Rheumatology (Oxford); 2020 Mar; 59(3):634-640. PubMed ID: 31436287 [TBL] [Abstract][Full Text] [Related]
18. Clinical profiles differ in IgG4-related disease with and without allergy: a large case-control study in China. Zhao Z; Liu Y; Bai M; Zeng Q; Wang Z; Chen D; Li Z; Su Y Clin Exp Rheumatol; 2023 Sep; 41(9):1808-1814. PubMed ID: 36826798 [TBL] [Abstract][Full Text] [Related]
19. IgG4 Related Autoimmune Pancreatitis: An Overview and the Emerging Role of Serum Eotaxin as a Potential Treatment Target. Mari A; Kadah A; Mahamid M; Sbeit W; Khoury T Isr Med Assoc J; 2019 Sep; 21(9):620-623. PubMed ID: 31542909 [TBL] [Abstract][Full Text] [Related]
20. Role of eosinophilia in IgG4-related disease. Ming B; Zhong J; Dong L Clin Exp Rheumatol; 2022 May; 40(5):1038-1044. PubMed ID: 34369362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]